Assessing outcomes of intravenous insulin therapy in non-intensive care patients.
Mercedes Martinez GilRodrigo FonsecaLeila K TehraniJanna C CastroShon E MeekBithika M ThompsonCurtiss B CookPublished in: Hospital practice (1995) (2024)
A large number (468) of ICU days were avoided by providing IVII in the non-ICU setting. Of the more than 400 days of IVII therapy provided in the non-ICU, only 7 medication errors occurred. Further studies are needed to optimize IVII strategy for non-ICU patients.
Keyphrases
- end stage renal disease
- intensive care unit
- newly diagnosed
- ejection fraction
- chronic kidney disease
- type diabetes
- healthcare
- peritoneal dialysis
- stem cells
- emergency department
- patient safety
- metabolic syndrome
- high dose
- adipose tissue
- patient reported outcomes
- bone marrow
- electronic health record
- acute respiratory distress syndrome
- patient reported
- smoking cessation
- drug induced